Profile: Hubei Honch Pharmaceutical Co.,Ltd produces anti-tumor medicine and pharmaceutical material. Our products consist of vinorelbine tartrate, docetaxel, paclitaxel, vinorelbine and vinblastine sulfate pharmaceutical materials. Our vinorelbine tartrate is used as an antineoplastic agent, half synthesis derivative of vincamedine for the equilibrium of microtubule. Our product line includes active pharmaceutical ingredients, intermediates and western medicines. Our APIs include vinorelbine tartrate, vinblastine sulfate, docetaxel, paclitaxel, vinorelbine, topotecan hydrochloride, irinotecan hydrochloride trihydrate and camptothecin. Vinorelbine tartrate is a antineoplastic agent, half synthesis derivative of vincamedine for the equilibrium of microtubule protein. Docetaxel is a white powder. The mechanism strengthens the microtubule protein polymerization and suppresses depolimerization causing stable non-functionality and thus destructing cell's mitosis.